- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00792779
Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty
November 4, 2009 updated by: Centro Medico Campinas
The purpose of this study is to determine if propofol could protect erythrocytes by directly scavenging free radicals from the blood current and increasing resistance of their cell membranes in patients submitted to gastroplasty.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Campinas, São Paulo, Brazil, 13084-000
- Fundação Centro Médico de Campinas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients between BMI 40-50 kg/m2
Exclusion Criteria:
- patients with BMI under 40 kg/m2 and over 50 kg/m2
- alcohol users
- illicit-drug users
- patients in regular use of anti-depressants, proton bomb inhibitors or calcium canal blockers
- patients transfused either recently, during the intra-operative period or within 10 hours post-operative
- patients previously known to be hypersensitive to any drug that is used during the study
- patients with any psychiatric disorder or dementia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Count erythrocytes
Time Frame: After 10 hours post-surgery
|
After 10 hours post-surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Bilirubins(direct and indirect)
Time Frame: After 10 hours post-surgery
|
After 10 hours post-surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ricardo F Simoni, MD, Fundação Centro Médico de Campinas
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2008
Primary Completion (Anticipated)
May 1, 2009
Study Completion (Anticipated)
June 1, 2009
Study Registration Dates
First Submitted
November 17, 2008
First Submitted That Met QC Criteria
November 17, 2008
First Posted (Estimate)
November 18, 2008
Study Record Updates
Last Update Posted (Estimate)
November 5, 2009
Last Update Submitted That Met QC Criteria
November 4, 2009
Last Verified
November 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAAE - 0023.0.263.000-08
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemolysis
-
Guy's and St Thomas' NHS Foundation TrustUniversity of OxfordNot yet recruitingHemolysis Neonatal
-
Hadassah Medical OrganizationUnknown
-
National Institutes of Health Clinical Center (CC)CompletedIsoagglutinin-Mediated Hemolysis | Probiotic ToxicityUnited States
-
Hospices Civils de LyonCompletedChronic HemolysisFrance
-
Cedars-Sinai Medical CenterNot yet recruitingAcute Decompensated Heart Failure | Hemolysis IntravascularUnited States
-
Massachusetts General HospitalSpina, Stefano, M.D., Massachusetts General Hospital; Marrazzo, Francesco,... and other collaboratorsRecruitingCardiovascular Diseases | Endothelial Dysfunction | Cardiovascular Risk Factor | Hemolysis IntravascularUnited States
-
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion...Leiden University Medical CenterCompleted
-
Medical University of GrazJoanneum Research Forschungsgesellschaft mbHCompleted
-
CARE Pharma Shanghai Ltd.Recruiting
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
Clinical Trials on Propofol
-
Hopital FochCompleted
-
Konkuk University Medical CenterCompletedCoronary Artery Disease | Valvular Heart DiseaseKorea, Republic of
-
University Medical Center GroningenCompletedAnesthesia | Hemodynamic Instability | Interaction | Disorder of Oxygen TransportNetherlands
-
Asan Medical CenterCompletedPopulation Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy VolunteersHealthyKorea, Republic of
-
Tiva GroupMedtronic - MITGCompleted
-
Pontificia Universidad Catolica de ChileCompletedSurgery | Anesthesia | Depth of Anesthesia | NeonateChile
-
Mansoura UniversityCompleted
-
KVG Medical College and HospitalUnknown
-
Acibadem UniversityCompleted